CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
Recruiting · NCT07294677 · Registry updated 2026-03-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-03-04 | NCT07294677 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Chicago | 326 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Chicago Medicine Comprehensive Cancer Center | Chicago | United States | 26 |